Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease

A J Russo1, A Krigsman, B Jepson

  • 1Research Director, Health Research Institute/Pfeiffer Treatment Center, 4575 Weaver Parkway, Warrenville, Illinois 60555, USA.

Biomarker Insights
|December 24, 2009
PubMed

Insights

Serum Hepatocyte Growth Factor (HGF) levels are significantly lower in autistic children with gastrointestinal (GI) disease. This finding suggests HGF may be a biomarker for GI issues in autism.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Gastroenterology

Background:

  • Autism Spectrum Disorder (ASD) is often associated with gastrointestinal (GI) dysfunction.
  • Hepatocyte Growth Factor (HGF) plays a crucial role in tissue repair and regeneration.
  • Altered HGF levels have been implicated in various inflammatory and developmental conditions.

Purpose of the Study:

  • To investigate serum Hepatocyte Growth Factor (HGF) levels in autistic children presenting with severe gastrointestinal (GI) disease.
  • To determine if there is a correlation between the severity of GI pathology and HGF concentration in this population.

Main Methods:

  • Serum samples were collected from 29 autistic children with chronic GI disease and compared to 31 controls.
  • HGF levels were quantified using enzyme-linked immunosorbent assays (ELISAs).
  • GI disease severity was assessed and correlated with HGF levels.

Main Results:

  • Autistic children with GI disease exhibited significantly lower serum HGF levels compared to all control groups.
  • A collective comparison showed significantly lower HGF levels in all autistic children versus non-autistic children.
  • No significant relationship was found between the severity of GI disease and HGF concentration in autistic children with GI issues.

Conclusions:

  • The study indicates a strong association between reduced serum HGF levels and the presence of GI disease in autistic children.
  • These findings suggest a potential functional link between the Met gene, HGF, and autism.
  • Serum HGF may serve as a valuable biomarker for identifying GI disease in autistic children, particularly those with severe symptoms.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...